Relevant bibliographies by topics / Drug utilization

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Drug utilization'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drug utilization.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drug utilization"

1

Munjely, Elza Joy, Bindu Latha Nair R., and Varghese P. Punnoose. "Drug utilization pattern in Schizophrenia." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1572. http://dx.doi.org/10.18203/2319-2003.ijbcp20192652.

Full text
Abstract:
Background: Pharmacotherapy is the mainstay of treatment in schizophrenia. The economic impact of this illness is wide ranging, long lasting and huge. The emergence of newer antipsychotics has changed the prescribing pattern. Purpose of this study is to determine the prescription pattern of antipsychotic drugs and to analyse the drug utilization in patients with schizophrenia based on WHO prescribing indicators.Methods: A descriptive study was conducted for a period of 1-year duration at inpatient Department of Psychiatry of a Government Medical College in Kerala, India among 230 schizophrenic patients. The case sheets of patients meeting inclusion criteria were scrutinised to find out the antipsychotic prescription pattern and drug utilization was analysed using WHO prescribing indicators. Analysis was done using descriptive statistics.Results: Newer antipsychotics (55.2%) were prescribed slightly more in preference to older antipsychotic (44.8%) drugs. Out of the newer drugs prescribed olanzapine (20.9%) was prescribed the most followed by risperidone (18%). Haloperidol (22.9%) was the most frequently prescribed older antipsychotic. Majority (71.3%) of the patients were given more than one antipsychotics during the hospital stay. Trihexyphenidyl (27.9%) was the most frequently co-prescribed drug with antipsychotics. Average number of drugs per encounter was 4.19, 73.4% of the drugs were prescribed in their generic name, 50.4% of the encounters were with an injection prescribed. 44.4%of the drugs were prescribed from the EDL (WHO-19th edition). Average drug cost per encounter was Rs.45.43. Percentage of drug cost spent on injections was 8.44%.Conclusions: Newer antipsychotics were more prescribed for schizophrenia of which olanzapine was the commonest. Newer antipsychotics are preferred because of their propensity to cause less side effects and more efficacy. Study of pattern of drug utilization is useful for measuring the economic impact of drug use among patients thereby facilitating rational prescribing.
APA, Harvard, Vancouver, ISO, and other styles
2

Singh, Uday, Gurjeet Singh, and Randhir Singh. "A STUDY ON DRUG UTILIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN TERTIARY CARE HOSPITAL." INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 7, no. 2 (2020): 2184–93. http://dx.doi.org/10.21276/irjps.2020.7.2.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meena, Dinesh Kumar, and M. Jayanthi. "Drug utilization research: a review." International Journal of Basic & Clinical Pharmacology 8, no. 2 (2019): 354. http://dx.doi.org/10.18203/2319-2003.ijbcp20190161.

Full text
Abstract:
Data from drug utilization research is an invaluable resource for all stake holders involved in drug and health policies. Drug utilization is “marketing, distribution, prescription and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences”. Research on drug utilization includes factors related to prescribing, dispensing, administering and intake of medication and its associated events. The ultimate purpose of drug utilization research is to estimate the optimal quality of drug therapy by identifying, documenting, analysing problems in drug utilization and monitoring the consequences. It encourages the prescribers to prescribe correct drug at appropriate dose and affordable price. It contributes to the knowledge of rational use of drugs in the society; whether the drug is being prescribed appropriately, whether the drug is taken in correct dosage, whether the drug is available at affordable price or misused. It provides valuable feedback about the rationality of the prescription to the doctors. It also assesses whether an intervention affects the drug use in the population by examining the outcomes of different types of intervention given to improve rationality in drug use. Drug utilization research can be qualitative or quantitative and can be done by various methods. This review highlights the understanding of various aspects, different designs and WHO guidelines for conducting drug utilization research.
APA, Harvard, Vancouver, ISO, and other styles
4

Lefkowitz-Ziegler, Pat. "Drug Utilization Evaluation." Journal For Healthcare Quality 11, no. 3 (1989): 16–17. http://dx.doi.org/10.1111/j.1945-1474.1989.tb00413.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Farrar, John T., and Brian L. Strom. "Drug utilization evaluation." Journal of General Internal Medicine 10, no. 9 (1995): 530–31. http://dx.doi.org/10.1007/bf02602414.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Merin, Daniel, D. R. Bharathi, and G.R Nataraj. "Drug Utilization Trends in ENT Outpatients." International Journal of Science and Healthcare Research 3, no. 4 (2018): 166–71. https://doi.org/10.5281/zenodo.3937241.

Full text
Abstract:
<strong>Background:&nbsp;</strong>Infection of Ear, nose and throat (ENT) are common clinical problems occurring in the general population and are a cause of serious morbidity and debility. Drug Utilization is defined by the WHO as the &ldquo;marketing, distribution, prescription, and use of drugs in society. The characterization of drug utilization may be extended linking prescription data to the reasons for the drug prescribing by various types of health professionals. <strong>Objectives</strong>: Assessment of disease pattern, prescription trends and mean cost per prescription in ENT outpatients which provides an insight about the drug utilization. <strong>Methodology:</strong>A prospective observational study was carried out for a period of six months at ENT department of Basaveshwara Medical College &amp; Hospital, Chitradurga. <strong>Results:</strong>&nbsp;A total of 157 patients were enrolled for the study of which 62 were males and 95 were females. Majority of patients were in the age group of 21-30 years. Maximum number of patients diagnosed with acute tonsillopharyngitis (35%). Antibiotics were most frequently prescribed drugs followed by Anti-gastric drugs, NSAIDs, Anti-allergic, Nasal decongestant, Anti-secretory agent, Anti-amoebic agents. Average number of drug per prescription was 3.46 and mean cost of drugs per prescription in females (389) were more than male (339.82). All the drugs were prescribed with their brand names. <strong>Conclusion:&nbsp;</strong>The study revealed that pattern of usage of antibiotics are more compared to other drugs, Azithromycin are most commonly prescribed antibiotics in various ENT diseases, usage of brand name are higher than the generic name. &nbsp;
APA, Harvard, Vancouver, ISO, and other styles
7

Abel, sabu Viresh. k. chandur. "Analysis Of Drug Utilization Patterns In The Intensive Care Unit Of A Tertiary Care Hospital Using Who Core Prescribing Indicators A Retrospective Study." International Journal in Pharmaceutical Sciences 1, no. 11 (2023): 542–50. https://doi.org/10.5281/zenodo.10207442.

Full text
Abstract:
Objective: The aim of this study was to analyze the drug utilization patterns in the Intensive Care Unit (ICU) of a tertiary care hospital using the World Health Organization (WHO) core prescribing indicators.Methods: A retrospective analysis of medication prescriptions in the ICU was conducted. The WHO core prescribing indicators, including the average number of drugs per prescription, percentage of prescriptions involving injections, percentage of prescriptions involving antibiotics, percentage of drugs prescribed by generic name, and percentage of drugs prescribed from the Essential Drug List/Formulary, were calculated.Results: The study included 100 patients admitted to the ICU. The average number of drugs prescribed per patient was found to be 11.2&nbsp; , exceeding the recommended norm. Injections were prescribed in 78% of the prescriptions, which surpassed the ideal threshold. Antibiotics were prescribed in 99% of the prescriptions, significantly higher than the standard range. The percentage of drugs prescribed by generic name was 14.1%, indicating scope for improvement. The percentage of drugs prescribed from the Essential Drug List/Formulary was 50.17%, demonstrating moderate adherence.Conclusion: The analysis of drug utilization patterns in the ICU highlighted areas of concern, such as polypharmacy, excessive use of injections, and high antibiotic prescribing rates. These findings emphasize the need for interventions to optimize prescribing practices, promote rational drug use, and enhance adherence to essential drug lists. Addressing these patterns can improve patient outcomes, reduce healthcare costs, and mitigate the risks associated with inappropriate medication use in the ICUcosts, and mitigate the risks associated with inappropriate medication use in the ICU.
APA, Harvard, Vancouver, ISO, and other styles
8

S, Shalini, Ravichandran V, Saraswathi R, BK Mohanty, and Dhanaraj S K. "Drug Utilization Studies – An Overview." International Journal of Pharmaceutical Sciences and Nanotechnology 3, no. 1 (2010): 803–10. http://dx.doi.org/10.37285/ijpsn.2010.3.1.2.

Full text
Abstract:
Aspire of the Drug Utilization Studies (DUS) is to appraise factors related to the prescribing, dispensing, administering and taking of medication, and it’s associated. Since the middle of twentieth century, interest in DUS has been escalating, first for market-only purposes, then for appraising the quality of medical prescription and comparing patterns of use of specific drugs. The scope of DUS is to evaluate the current state and future trends of drug usage, to estimate roughly disease pervasiveness, drug expenditures, aptness of prescriptions and adherence to evidence-based recommendations. The increasing magnitude of DUS as a valuable investigation resource in pharmacoepidemiology has been bridging it with other health allied areas, such as public health, rational use of drug, evidence based drug use, pharmacovigilance, pharmacoeconomics, eco-pharmacovigilance and pharmacogenetics.
APA, Harvard, Vancouver, ISO, and other styles
9

Philip Jacob, Arul Balasubramanian, and Kothai Ramalingam. "A review on steps involved in drug utilization review." International Journal of Research in Pharmaceutical Sciences 11, no. 3 (2020): 4095–98. http://dx.doi.org/10.26452/ijrps.v11i3.2612.

Full text
Abstract:
Drug Utilization is also known as Drug Utilization Review, is an arrangement of persistent, orderly, criteria based medication assessment that guarantees the proper usage of drugs. Drug use/ utilization evaluation and medication utilization evaluations are the same as drug utilization review. It is a technique for acquiring data to recognize the problems related to the usage of drugs and if appropriately created, it also gives a method for revising the issue and in this way, it becomes a factor in reasonable drug usage. Evaluation of use can survey the real procedure of medication administration or dispensing of proper medication and furthermore the results of treatment. Drug utilization review services include corrective actions, prescriber reviews and further evaluations as a quality assurance mechanism. This article reviews the drug utilization pattern and evaluation of the process of drug utilization. The evaluation pattern can be classified into several categories such as prospective, concurrent and retrospective. The drug utilization evaluation process is a continuous cycle and its maximum effect is attained when it is conducted as a cycle rather than conducting in steps. This evidence-based approach with utilization of the medication is intended to depend on the best accessible clinical evidence to create explicit rules for a particular illness or utilization of a particular medication.
APA, Harvard, Vancouver, ISO, and other styles
10

Braj, Nandan Kumar Sah, Sultana Sara, and Kumar Jeetendra. "A Study on Drug Utilization in Geriatric Patients." International Journal of Pharmaceutical and Clinical Research 13, no. 6 (2021): 745–50. https://doi.org/10.5281/zenodo.14227108.

Full text
Abstract:
<strong>Objectives:&nbsp;</strong>This present was to evaluate the drug utilization and clinical conditions in geriatric patients.&nbsp;<strong>Methods:&nbsp;</strong>A total of 100 geriatric patients with age group 65 to &ge; 80 years were enrolled in this study. Rationality of prescriptions was analysed using WHO prescribing indicators. This includes five indicators which are &ndash; average number of drugs per prescription, drugs prescribed by generic name, number of antibiotics prescribed, number of injections prescribed, and drugs prescribed from essential medicines list.&nbsp;<strong>Results:&nbsp;</strong>Majorities of patients 63(63%) were in age group of 65-70 years. 67(67%) patients were males, and 33(33%) patients were females. The most common condition for admission in medical ward were cardiovascular disorders 33(33%) followed by respiratory distress 21(21%), genitourinary disorders 18(18%) and gastrointestinal conditions 7(7%). A total 834 drugs were prescribed. Average drug prescription was 8.34.&nbsp;<strong>Conclusions:&nbsp;</strong>Preponderance of geriatric patients are more in male. Most common conditions are cardiovascular disorders followed by respiratory disorders and genitourinary disorders in geriatric patients. Hence, geriatric patients are more prone to multiple disorders and more dependent on multiple drugs. So that, health care concerns should always monitor the drugs utilization to minimise the risk for adverse effect.&nbsp; Safer drug utilization may help in improving the quality of life in geriatric patients. &nbsp; &nbsp; &nbsp;
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drug utilization"

1

Bardel, Annika. "Women's Health and Drug Utilization." Doctoral thesis, Uppsala University, Department of Public Health and Caring Sciences, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8225.

Full text
Abstract:
<p><b>Objectives</b>. To study medication utilization and adherence to prescribed therapy in a female population in central Sweden. To study usage of hormone replacement therapy (HRT) in this population and to assess how HRT users compare to non-users regarding symptom reporting, general health and other variables. To evaluate symptom prevalence adjusted for potential symptom affecting variables. </p><p><b>Material and methods</b>. A cross-sectional postal questionnaire study was performed in 1995 in seven counties in central Sweden. A questionnaire was sent to a random sample of 4,200 women aged 35-64, of whom 2,991 responded (71.2%). The questionnaire contained questions on psycho-socio-economic background, quality of life, self-reported health, height and weight, climacteric symptom prevalence, and menopausal status and symptoms. It also comprised questions on medication prescribed during the past year. </p><p><b>Results</b>. 40% used prescribed medication and 12% took four drugs or more. Age, educational level, self-rated health, and BMI remained significantly correlated to drug use in multivariate analysis. Adherence ranged from 15%-98% depending on age, a scheduled check-up, perceived importance of medication, concern about medication, taking cardiovascular and respiratory disease drugs. The highest adherence was found for hormonal medication the lowest for musculoskeletal medication. </p><p>HRT was used by 15% of the women. 13 % used other symptom relieving therapy. HRT users reported higher score of vasomotor symptoms, except for sweating during the daytime. </p><p>Prevalence of general symptoms did not necessarily increase with age. Especially symptoms related to stress-tension-depression decreased with age. Four different symptom prevalence patterns were found. </p><p><b>Conclusions</b>. Age, health status, educational level and body mass index (BMI) appear to affect drug use. Adherence to therapy is highest among elderly women who regard their medication as important and have a scheduled check-up. HRT relieves some vasomotor symptoms but does not affect other symptoms or self-rated health. Prevalence of symptoms related to Stress-tension-depression appears to decrease with age.</p>
APA, Harvard, Vancouver, ISO, and other styles
2

Pittrow, David, Wilhelm Kirch, Peter Bramlage, et al. "Patterns of antihypertensive drug utilization in primary care." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2013. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-105346.

Full text
Abstract:
Background: In the treatment of hypertension, physicians’ attitudes and practice patterns are receiving increased attention as contributors to poor blood pressure (BP) control. Thus, current use of antihypertensive drugs in primary care was analyzed and the association with selected physician and patient characteristics was assessed. Methods: The Hypertension and Diabetes Risk Screening and Awareness (HYDRA) study is a cross-sectional point prevalence study of 45,125 primary care attendees recruited from a representative nationwide sample of 1912 primary care practices in Germany. Prescription frequencies of the various antihypertensive drugs in the individual patients were recorded by the physicians using standardized questionnaires. We assessed the association of patient variables [age, gender; co-morbidities such as diabetes, nephropathy or coronary heart disease (CHD)] and physician variables (general practitioner vs internist, guideline adherence, etc.) with drug treatment intensity and prescription patterns. Results: Of all 43,549 patients for whom a physician diagnosis on hypertension or diabetes was available, 17,485 (40.1%) had hypertension. Of these hypertensive patients, 1647 (9.4%) received no treatment at all, 1191 (6.8%) received non-pharmacological measures only, and 14,647 (83.8%) were given one or more antihypertensive drugs. Drug treatment rates were lower in young patients (16–40 years: 57.4%). BP control was poor: 70.6% of all patients were not normalized, i.e., had BP ≥140/90 mmHg. Antihypertensive treatment was generally intensified with increasing age, or if complications or comorbidities were present. The use of the different drug classes was rather uniform across the various patient subgroups (e.g., by age and gender). Individualized treatment with regard to co-morbidities as recommended in guidelines was not the rule. Adherence to guidelines as self-reported by physicians as well as other physician characteristics (region, training etc.) did not result in more differentiated prescription pattern. Conclusions: Despite the broad armamentarium of drug treatment options, physicians in primary care did not treat hypertension aggressively enough. Treatment was only intensified at a late stage, after complications had occurred. Treatment should be more differentiated in terms of coexisting morbidities such as diabetes, nephropathy, or CHD.
APA, Harvard, Vancouver, ISO, and other styles
3

Sousa, Helena Alexandra Soares Gama de. "Drug utilization studies: Focus on questionnaire design." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2007. http://hdl.handle.net/10216/22094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sousa, Helena Alexandra Soares Gama de. "Drug utilization studies: Focus on questionnaire design." Dissertação, Faculdade de Medicina da Universidade do Porto, 2007. http://hdl.handle.net/10216/22094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Al-Dhewalia, Hamad Mohammed 1955. "The quality of drug prescribing in a multinational medical setting." Thesis, The University of Arizona, 1988. http://hdl.handle.net/10150/276834.

Full text
Abstract:
The objectives of this study were to investigate the hypotheses that: (1) Job satisfaction is related to medical specialty, the physician's nationality, and length of tenure. (2) The physician's attitude toward the Drug Utilization Review (DUR) program is related to medical specialty, the place of residency training, length of tenure, and job satisfaction. (3) The quality of drug prescribing is related to medical specialty, the place of residency training, length of tenure, job satisfaction, and the physician's attitude toward the DUR program. The results indicated a significant relationship between the physician's nationality and job satisfaction (P = 0.001), and between job satisfaction and the physician's attitude toward the DUR program (P 0.001). Medical specialty was a strong independent predictor of the quality of drug prescribing (P = 0.002). However, the other independent variables of the locale of residency training, length of tenure, job satisfaction, and the physician's attitude toward the DUR program were not related to drug prescribing.
APA, Harvard, Vancouver, ISO, and other styles
6

Kou, Maybelle Antonia Maria. "Quantitative and qualitative drug utilization studies in a university teaching hospital in Hong Kong." Thesis, [Hong Kong : University of Hong Kong], 1994. http://sunzi.lib.hku.hk/hkuto/record.jsp?B14436711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kamat, Siddhesh Ajit. "Development and validation of a measure to assess physician readiness to prescribe drug therapies for post myocardial infarction patients." Morgantown, W. Va. : [West Virginia University Libraries], 2003. http://etd.wvu.edu/templates/showETD.cfm?recnum=3291.

Full text
Abstract:
Thesis (M.S.)--West Virginia University, 2003.<br>Title from document title page. Document formatted into pages; contains xi, 124 p. : ill. (some col.) Includes abstract. Includes bibliographical references (p. 94-104).
APA, Harvard, Vancouver, ISO, and other styles
8

Kiivet, Raul-Allan. "Drug utilization studies as support to decisions in drug policy in Estonia /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3639-0/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pittrow, David, Wilhelm Kirch, Peter Bramlage, et al. "Patterns of antihypertensive drug utilization in primary care." Technische Universität Dresden, 2004. https://tud.qucosa.de/id/qucosa%3A26584.

Full text
Abstract:
Background: In the treatment of hypertension, physicians’ attitudes and practice patterns are receiving increased attention as contributors to poor blood pressure (BP) control. Thus, current use of antihypertensive drugs in primary care was analyzed and the association with selected physician and patient characteristics was assessed. Methods: The Hypertension and Diabetes Risk Screening and Awareness (HYDRA) study is a cross-sectional point prevalence study of 45,125 primary care attendees recruited from a representative nationwide sample of 1912 primary care practices in Germany. Prescription frequencies of the various antihypertensive drugs in the individual patients were recorded by the physicians using standardized questionnaires. We assessed the association of patient variables [age, gender; co-morbidities such as diabetes, nephropathy or coronary heart disease (CHD)] and physician variables (general practitioner vs internist, guideline adherence, etc.) with drug treatment intensity and prescription patterns. Results: Of all 43,549 patients for whom a physician diagnosis on hypertension or diabetes was available, 17,485 (40.1%) had hypertension. Of these hypertensive patients, 1647 (9.4%) received no treatment at all, 1191 (6.8%) received non-pharmacological measures only, and 14,647 (83.8%) were given one or more antihypertensive drugs. Drug treatment rates were lower in young patients (16–40 years: 57.4%). BP control was poor: 70.6% of all patients were not normalized, i.e., had BP ≥140/90 mmHg. Antihypertensive treatment was generally intensified with increasing age, or if complications or comorbidities were present. The use of the different drug classes was rather uniform across the various patient subgroups (e.g., by age and gender). Individualized treatment with regard to co-morbidities as recommended in guidelines was not the rule. Adherence to guidelines as self-reported by physicians as well as other physician characteristics (region, training etc.) did not result in more differentiated prescription pattern. Conclusions: Despite the broad armamentarium of drug treatment options, physicians in primary care did not treat hypertension aggressively enough. Treatment was only intensified at a late stage, after complications had occurred. Treatment should be more differentiated in terms of coexisting morbidities such as diabetes, nephropathy, or CHD.
APA, Harvard, Vancouver, ISO, and other styles
10

De, Young Paul. "Effect of Medicaid prior authorization on drug utilization." CONNECT TO ELECTRONIC THESIS, 2007. http://dspace.wrlc.org/handle/1961/4249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drug utilization"

1

Elseviers, Monique, Björn Wettermark, Anna Birna Almarsdóttir, et al., eds. Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

WHO Expert Committee on the Use of Essential Drugs. Meeting, ed. The Use of essential drugs: Second report of the WHO Expert Committee. World Health Organization, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Le, Huong. Drug utilization review on ceftizoxime. Ottawa General Hospital], 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schroeder, Elizabeth Erika. Drug utilization review of cefamandole. St. Joseph's Hospital, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Health, Ontario Ministry of. Drug Utilization: A Comprehensive Literature Review. Drug Prescription. s.n, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

WHO Expert Committee on the Use of Essential Drugs. Meeting, ed. The Use of essential drugs: Model list of essential drugs (seventh list) : fifth report of the WHO Expert Committee. World Health Organization, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

WHO Expert Committee on the Use of Essential Drugs. Meeting, ed. The Use of essential drugs: Third report of the WHO Expert Committee. World Health Organization, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

G, Dukes M. N., and World Health Organization. Regional Office for Europe., eds. Drug utilization studies: Methods and uses. World Health Organization, Regional Office for Europe, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sánchez, Carlos Cuauhtémoc. En pie de guerra contra las drogas. Ediciones Selectas Diamante, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nepal. Dept. of Drug Administration. National list of essential drugs Nepal. Ministry of Health, Dept. of Drug Administration, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Drug utilization"

1

Wilking, Nils, Thomas Hofmarcher, Ulla Wilking, and Bengt Jönsson. "Drug utilization research in the area of cancer drugs." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wettermark, Björn, Monique Elseviers, Anna Birna Almarsdóttir, et al. "Introduction to drug utilization research." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Matuz, Maria, Ria Benko, and Mikael Hoffmann. "Visualization of drug utilization data." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Merlo, Juan. "Multilevel analyses in drug utilization research." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Campbell, Stephen, Björn Wettermark, and Morten Andersen. "Defining and developing quality indicators for drug utilization." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Almarsdóttir, Anna Birna, and Pia Bastholm Rahmner. "Qualitative methods in drug utilization research." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vlahovic´-Palcˇevski, Vera, Björn Wettermark, Luisa Ibáñez, and Robert Vander Stichele. "Comparison of drug utilization across different geographical areas." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MacBride-Stewart, Sean, Ksenia Zagorodnikova, Irene Langner, and Gisbert W. Selke. "Comparison of drug utilization in different health care settings." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ganse, Eric Van, Laurent Laforest, and Niels Adriaenssens. "Time-dependent and seasonal variations in drug utilization." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Eriksson, Irene, Ulf Bergman, Vera Vlahovic´-Palcˇevski, and Mia von Euler. "Comparative studies of patient and prescriber characteristics." In Drug Utilization Research. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118949740.ch17.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drug utilization"

1

Demadis, Konstantinos D., Argyro Spinthaki, Georgia Skordalou, Ioannis Aristodemou, and Aikaterini Zepou. "Influence of Structural Features of Scale Inhibitors on the Control of Silica Scaling." In CORROSION 2019. NACE International, 2019. https://doi.org/10.5006/c2019-12861.

Full text
Abstract:
Abstract Silica formation is an event that takes place in the biological and industrial world. Marine biological systems annually process 6.7 gigatons of “Si”. In industry, silica is used for a plethora of applications (filler, drug excipient, catalyst support, etc.), but in water treatment systems it is a problem, as it forms undesirable precipitates and deposits. It is, therefore, imperative to combat the problem of precipitation/deposition by approaches that focus on the stabilization of soluble forms of silica (mainly monosilicic acid, Si(OH)4). Among the various approaches the use of chemical inhibitors is the most effective strategy. Additives are being utilized successfully for several inorganic mineral scales (eg. CaCO3, BaSO4, etc.), however, silica is a case with intriguing idiosyncracies. Its control requires designed strategies based on its unique chemical nature. Thus, additives that are efficient for other mineral scales are totally ineffective for silica. We have devised chemical approaches to combat silica scaling in water systems, which include utilization of polyelectrolytes possessing “active” chemical moieties, capable of stabilizing silicic acid. These polymers reduce the rate of silicic acid condensation, and influence silica particle growth. Possible mechanisms are discussed, focusing on the nature of chemical moieties responsible for the stabilization.
APA, Harvard, Vancouver, ISO, and other styles
2

Fisher, George, and Ben Gilmore. "High Build PVDF Fluorocarbon Polymer Coatings Corrosion Resistant Applications." In CORROSION 2018. NACE International, 2018. https://doi.org/10.5006/c2018-11286.

Full text
Abstract:
Abstract With recent innovations and developments, PVDF electrostatically applied powder coatings can now achieve thicknesses from 2 to 10mm. There is significant opportunity for extending the service life of equipment in harsh chemical and abrasive applications with thick PVDF coatings. We have observed failures of traditional elastomeric, epoxy, FRP, and urethane linings and coatings where PVDF has greatly increased the service life of equipment such as mixers, agitators, vessels, and drum filters. Heretofore, this PVDF electrostatic coating technology was limited in scope due to poor adhesion, porosity and shrinkage. These problems have been overcome creating a very viable alternative to less chemical resistant materials for chemical and mineral processing. The advantages of a seamless, non-glued or welded lining are significant. PVDF fluorocarbon polymers possess a number of key advantages over other non-fluorinated materials and lining systems. The discussion and presentation of case histories illustrating these advantages and examples will be outlined in the paper. Furthermore, with the utilization of thermal spray equipment PVDF can be applied in the field joining together traditional oven coated parts making it possible to join together very large rake arms and clarifier components. By careful steps in the coating process and also the use of corrosion resistant fillers the upper thicknesses achievable can be as high as 10mm. These filled and unfilled PVDF coatings are bonded and adhere to metal substrates in excess of 2000 PSI.
APA, Harvard, Vancouver, ISO, and other styles
3

Syifa, Nailis, Cici Dwi, and Didik Hasmono. "Drug Utilization Study of Statin in Hemorrhagic Stroke." In Health Science International Conference (HSIC 2017). Atlantis Press, 2017. http://dx.doi.org/10.2991/hsic-17.2017.45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Baelum, Jesper, David Sherson, Trine Thilsing, et al. "Tracing asthma by drug utilization in young adults." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bouma, Barend. "Unlocking and optimal utilization of drug repurposing patenting potential: building a wall of protection and improving the odds of successfully providing patients with new therapies." In International Drug Repurposing Conference. ScienceOpen, 2024. http://dx.doi.org/10.14293/idr.23.002bb.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dilakshika, B. G. D., N. S. S. Dassanayake, W. W. R. Dunanja, et al. "Development of a drug management system to ensure drug availability for patients in the hospital." In Annual Academic Sessions-2024. Faculty of Medicine, University of Moratuwa, 2024. https://doi.org/10.31705/fomaas.2024.40.

Full text
Abstract:
Drug management is a critical component of healthcare, with precise medication dispensing being essential for both patient safety and efficient drug utilization. Globally, fully automated drug cabinets equipped with comprehensive drug tracking capabilities have been developed, along with advanced drug management software that assists healthcare providers in ensuring accurate and efficient medication management. In the Sri Lankan context drug management system heavily relies on manual criteria, causing errors and inefficiencies. This non-automated system negatively impacts patient care and resource management. This research aims to develop a hospital drug management system to ensure drug availability for patients.
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Tingting, Robert J. Prosser, M. Anne Smith, and Bruce Carleton. "Asthma Drug Regimens And Health Service Utilization: How Can We Improve Care?" In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph-fp.04.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies Under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.04.60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sadia, Halima. "Drug Regulatory Authority Of Pakistan, Karachi, Pakistan “Drug Utilization Evaluation Of Ceftriaxone In A Tertiary Care Teaching Hospital Of Karachi, Pakistan." In International Conference on Biological Research and Applied Science. Jinnah University for Women, Karachi,Pakistan, 2022. http://dx.doi.org/10.37962/ibras/2022/142-143.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Drug utilization"

1

Alpert, Abby, Darius Lakdawalla, and Neeraj Sood. Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D. National Bureau of Economic Research, 2015. http://dx.doi.org/10.3386/w21714.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Young, Taryn. How do pharmaceutical policies that restrict reimbursement for selected medications effect health outcomes, drug use and expenditures, and healthcare utilization? SUPPORT, 2016. http://dx.doi.org/10.30846/1608106.

Full text
Abstract:
Restrictions on reimbursement are defined as insurance policies that restrict reimbursement for selected drugs or drug classes, often using additional patient specific information related to health status or need.
APA, Harvard, Vancouver, ISO, and other styles
3

Ketcham, Jonathan, and Kosali Simon. Medicare Part D's Effects on Elderly Drug Costs and Utilization. National Bureau of Economic Research, 2008. http://dx.doi.org/10.3386/w14326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Buchmueller, Thomas, and Colleen Carey. The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare. National Bureau of Economic Research, 2017. http://dx.doi.org/10.3386/w23148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Crown, William, Ernst Berndt, Onur Baser, Stan Finkelstein, and Whitney Witt. Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter? National Bureau of Economic Research, 2003. http://dx.doi.org/10.3386/w10062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Conti, Rena, and Ernst Berndt. Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007. National Bureau of Economic Research, 2014. http://dx.doi.org/10.3386/w20016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khan, Nasreen, Robert Kaestner, and Swu Jane Lin. Prescription Drug Insurance and Its Effect on Utilization and Health of the Elderly. National Bureau of Economic Research, 2007. http://dx.doi.org/10.3386/w12848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lichtenberg, Frank. The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output. National Bureau of Economic Research, 2002. http://dx.doi.org/10.3386/w9139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mulligan, Casey. Ending Pay for PBM Performance: Consequences for Prescription Drug Prices, Utilization, and Government Spending. National Bureau of Economic Research, 2023. http://dx.doi.org/10.3386/w31667.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kleinhenz, Michael D., Patrick J. Gorden, and Johann F. Coetzee. Utilization of Liquid Chromatography/Mass Spectrometry to Detect Drug Residues in Milk: Applications for Research and Commercial Dairying. Iowa State University, 2005. http://dx.doi.org/10.31274/ans_air-180814-1158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Drug utilization' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography